BIOVERATIV INC (BIVV) Debt to Equity Ratio
Current and historical debt to equity ratio values for BIOVERATIV INC (BIVV) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$11.213B||$1.169B|
|Bioverativ Inc. is a biotechnology company. It focuses on the discovery, research, development, and commercialization of innovative therapies for the treatment of hemophilia and other blood disorders. Bioverativ Inc. is based in Waltham, United States.|